Patient risk factors for developing a drug-related problem in a cardiology ward.

PubWeight™: 0.87‹?›

🔗 View Article (PMC 4275111)

Published in Ther Clin Risk Manag on December 17, 2014

Authors

Olatz Urbina1, Olivia Ferrández1, Sònia Luque1, Santiago Grau2, Sergi Mojal3, Rosa Pellicer1, Marta Riu4, Esther Salas1, Josep Comin-Colet5

Author Affiliations

1: Pharmacy Department, Hospital Universitari del Mar, Barcelona, Spain.
2: Pharmacy Department, Hospital Universitari del Mar, Barcelona, Spain ; Universitat Autònoma de Barcelona, Barcelona, Spain.
3: Department of Statistics, Institut Hospital del Mar d'Investigacions Mèdiques, Barcelona, Spain.
4: Department of Epidemiology and Health Services Evaluation, CIBER de Epidemiología y Salud Pública (CIBERESP), Hospital Universitari del Mar, Barcelona, Spain.
5: Heart Failure Unit, Cardiology Department, Hospital Universitari del Mar, Barcelona, Spain.

Articles cited by this

The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group. JAMA (1997) 14.57

Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA (1997) 13.66

Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials. J Am Coll Cardiol (2004) 5.61

Systematic review of multidisciplinary interventions in heart failure. Heart (2005) 3.68

Patient risk factors for adverse drug events in hospitalized patients. ADE Prevention Study Group. Arch Intern Med (1999) 3.46

Development and validation of a score to assess risk of adverse drug reactions among in-hospital patients 65 years or older: the GerontoNet ADR risk score. Arch Intern Med (2010) 3.05

Trends in comorbidity, disability, and polypharmacy in heart failure. Am J Med (2011) 1.80

Influence of gender of physicians and patients on guideline-recommended treatment of chronic heart failure in a cross-sectional study. Eur J Heart Fail (2009) 1.78

The complexity and cost of drug regimens of older patients hospitalized with heart failure in the United States, 1998-2001. Arch Intern Med (2005) 1.32

The majority of hospitalised patients have drug-related problems: results from a prospective study in general hospitals. Eur J Clin Pharmacol (2004) 1.25

Cost of medication-related problems at a university hospital. Am J Health Syst Pharm (1995) 1.18

ASHP guidelines on pharmacy planning for implementation of computerized provider-order-entry systems in hospitals and health systems. Am J Health Syst Pharm (2011) 1.12

Relationship between drug-related problems and health outcomes: a cross-sectional study among cardiovascular patients. Pharm World Sci (2010) 1.08

Strategies to reduce the risk of iatrogenic illness in complex older adults. Age Ageing (2013) 1.03

A systematic review of the clinical and economic effectiveness of clinical pharmacist intervention in secondary prevention of cardiovascular disease. J Manag Care Pharm (2013) 1.01

Polypharmacy and comorbidity in heart failure. BMJ (2003) 0.99

Effect of medication review and cognitive behaviour treatment by community pharmacists of patients discharged from the hospital on drug related problems and compliance: design of a randomized controlled trial. BMC Public Health (2010) 0.90

Negative clinical outcomes associated with drug-related problems in heart failure (HF) outpatients: impact of a pharmacist in a multidisciplinary HF clinic. J Card Fail (2010) 0.86

Drug-related problems in medical wards with a computerized physician order entry system. J Clin Pharm Ther (2009) 0.84

Implementing critical pathways and a multidisciplinary team approach to cardiovascular disease management. Am J Cardiol (2008) 0.83

Design of a score to identify hospitalized patients at risk of drug-related problems. Pharmacoepidemiol Drug Saf (2014) 0.83

Drug-related problems and hospital admissions in cardiac transplant recipients. Ann Pharmacother (2012) 0.81

Global cardiovascular disease prevention: a call to action for nursing executive summary. J Cardiovasc Nurs (2013) 0.81

Clinical pharmacy services in heart failure: an opinion paper from the Heart Failure Society of America and American College of Clinical Pharmacy Cardiology Practice and Research Network. Pharmacotherapy (2013) 0.80

Specialist care of heart failure improves appropriate pharmacotherapy at the expense of greater polypharmacy and drug-interactions. Eur J Heart Fail (2004) 0.80

Electronic screening of medical records to detect inpatients at risk of drug-related problems. Pharm World Sci (2009) 0.78

Articles by these authors

Design of a score to identify hospitalized patients at risk of drug-related problems. Pharmacoepidemiol Drug Saf (2014) 0.83